Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
Journal of Translational Medicine|June 15, 2016
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoringNina Körber, Uta Behrends, Alexander Hapfelmeier, et al.
Science (New York, N.Y.)|June 14, 2014
Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"Yuchen Xia, Julie Lucifora, Florian Reisinger, et al.
Der Internist|January 6, 2022
[Antiviral drugs : Potent agents, promising therapies for COVID‑19 and therapeutic limitations]Jakob J Malin, Till Bunse, Christoph D Spinner, et al.
Microbial Biotechnology|October 1, 2011
Design of therapeutic vaccines: hepatitis B as an exampleSarah Kutscher, Tanja Bauer, Claudia Dembek, et al.
Virology Journal|August 11, 2019
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systemsFranziska Kugler, Ingo Drexler, Ulrike Protzer, et al.
Journal of Virology|July 27, 2007
Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferonsStéphanie Jost, Priscilla Turelli, Bastien Mangeat, et al.
Journal of Virology|April 14, 2004
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent mannerZhensheng Zhang, Ulrike Protzer, Zongyi Hu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Production and Purification of Adeno-Associated Viral Vectors for the Development of Immune-Competent Mouse Models of Persistent Hepatitis B Virus ReplicationLisa Schiller, Chunkyu Ko, Anna D Kosinska, et al.
Nature Communications|November 19, 2021
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody designHristo L Svilenov, Julia Sacherl, Ulrike Protzer, et al.
Journal of Hepatology|September 10, 2002
Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineagesYanhua Li, Hans Hacker, Annette Kopp-Schneider, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
Journal of Translational Medicine|June 15, 2016
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoringNina Körber, Uta Behrends, Alexander Hapfelmeier, et al.
Science (New York, N.Y.)|June 14, 2014
Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"Yuchen Xia, Julie Lucifora, Florian Reisinger, et al.
Der Internist|January 6, 2022
[Antiviral drugs : Potent agents, promising therapies for COVID‑19 and therapeutic limitations]Jakob J Malin, Till Bunse, Christoph D Spinner, et al.
Microbial Biotechnology|October 1, 2011
Design of therapeutic vaccines: hepatitis B as an exampleSarah Kutscher, Tanja Bauer, Claudia Dembek, et al.
Virology Journal|August 11, 2019
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systemsFranziska Kugler, Ingo Drexler, Ulrike Protzer, et al.
Journal of Virology|July 27, 2007
Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferonsStéphanie Jost, Priscilla Turelli, Bastien Mangeat, et al.
Journal of Virology|April 14, 2004
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent mannerZhensheng Zhang, Ulrike Protzer, Zongyi Hu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Production and Purification of Adeno-Associated Viral Vectors for the Development of Immune-Competent Mouse Models of Persistent Hepatitis B Virus ReplicationLisa Schiller, Chunkyu Ko, Anna D Kosinska, et al.
Nature Communications|November 19, 2021
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody designHristo L Svilenov, Julia Sacherl, Ulrike Protzer, et al.
Journal of Hepatology|September 10, 2002
Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineagesYanhua Li, Hans Hacker, Annette Kopp-Schneider, et al.
Pageof 31